History of malignancy other than gastric or gastroesophageal junction carcinoma within  years prior to screening, with the exception of those with a negligible risk of metastasis or death;
History of other malignancy within  years prior to screening, with the exception of those with a negligible risk of metastasis or death
Concurrent malignancies other than BCC, other than those with negligible risk of metastases or death
Malignancies other than disease under study within  years prior to Day  of Cycle  except those with a negligible risk of metastasis or death
History of malignancy other than pancreatic carcinoma within  years prior to screening, with the exception of those with a negligible risk of metastasis or death
History of malignancy other than NSLCL within  years prior to screening with the exception of malignancies with negligible risk of metastasis or death
Malignancies other than NSCLC within  years prior to enrollment, except for those curatively treated with negligible risk of metastasis or death
History of malignancy other than HCC within  years prior to screening, with the exception of malignancies with a negligible risk of metastasis or death
Active malignancies within  months with the exception of those with a negligible risk of metastasis or death
Any other malignancies within  years except those with negligible risk of metastasis or death
Malignancies other than disease under study within  years prior to Cycle , Day , with the exception of those with a negligible risk of metastasis or death
Concurrent history of malignancy other than cervical cancer within  years of first planned dose of REGN, except for tumors with negligible risk of metastasis
History of malignancy, including prior SCCHN primary tumors within  years prior to screening, with the exception of malignancies with a negligible risk of metastasis or death
